The two companies have tapped writer Grant Morrison, the influential and award-winning scribe known for All-Star Superman and ...

Research grounding generative AI in validated clinical knowledge sets a foundation for trustworthy clinical AI. Health ...

The Epic-ready PACS platform lets clinicians upload, read, and share diagnostic images from a web browser and create AI-assisted reports, with no on-site servers to maintain PLEASANTON, Calif., Sept.

The health tech unicorn, last valued at $1.26 billion, will soon offer AI assistants that can autonomously complete administrative tasks to save doctors’ time.

The acting general secretary of Nigeria Football (NFF), Dr Emmanuel Ikpeme has revealed the basic factors that brought back to the country the continental governing body’s A-License Coaching Course ...

The Department of Veterans Affairs is planning to expand the use of an artificial intelligence tool that records veteran-doctor conversations with patient consent after a series of rollouts it says ...

Amman, Aug. 10 (Petra) -- The number of building licenses issued in the Kingdom rose by 3.2 percent in the first half of 2026, reaching 12,070 compared with 11,700 in the same period of 2025, the ...

After testing the Kindle Scribe Colorsoft for two months, I found that it was made for a very specific kind of notetaker and reader. While the device is pretty and lightweight, it’s not something the ...

The licenses for most software are designed to take away your freedom to share and change it. By contrast, the GNU General Public License is intended to guarantee your freedom to share and change free ...

This article first appeared on GuruFocus. Scribe Therapeutics (NASDAQ:SCTX), a clinical-stage developer of gene therapies for heart disease, surged 67% on Friday after raising $128.7 million in an ...

Scribe Therapeutics has overshot its own expectations with an IPO that's set to bring in $128.7 million for the in vivo gene editing outfit. Scribe is issuing 8.6 million shares—above the 7.1 million ...

For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable effects for the masses. With its lead program on a path to ...